Qian Jiaming

[Expert Profile] Qian Jiaming, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in gastroenterology in China, working in the Department of Gastroenterology, Peking Union Medical College Hospital. She has long been dedicated to clinical diagnosis, treatment, and scientific research of Crohn's disease, ulcerative colitis, and difficult inflammatory bowel disease, and is a leading figure in the field of inflammatory bowel disease (IBD) in China.

[Education & Career] Professor Qian Jiaming graduated from Peking Union Medical College, completed systematic clinical training in the Department of Gastroenterology at PUMCH, and further studied at famous international inflammatory bowel disease centers. She has long served as Director of the Department of Gastroenterology at PUMCH, holding important academic positions including Vice Chair of the Gastroenterology Branch of the Chinese Medical Association. She has presided over grants from the National Natural Science Foundation of China and the National Key R&D Program, and is a senior authoritative expert in the field of inflammatory bowel disease in China.

[Areas of Expertise] Professor Qian specializes in the diagnosis and treatment of Crohn's disease, ulcerative colitis, and difficult inflammatory bowel disease (IBD), as well as comprehensive diagnosis and treatment of various difficult digestive system diseases. She has extensive experience in precise IBD subtyping, colonoscopy and capsule endoscopy assessment, and standardized application of biologics (anti-TNF, anti-integrin, etc.) and novel small molecule drugs. She excels at managing difficult IBD patients with "years of abdominal pain and diarrhea and recurrent intestinal obstruction," helping numerous patients control inflammation, heal mucosa, and avoid surgery.

[Academic Achievements & Industry Contributions] Professor Qian has led the establishment of a Chinese inflammatory bowel disease clinical cohort and national collaboration network, systematically studying the clinical characteristics, disease progression, and treatment strategies of Chinese IBD patients, with findings published in authoritative domestic and international journals. She has led the development of Chinese inflammatory bowel disease diagnosis and treatment guidelines and expert consensus statements, actively promoted standardized IBD diagnosis and treatment and specialty clinic construction, and led multi-center clinical trials, significantly improving the overall diagnosis and treatment level of inflammatory bowel disease in China, and making important contributions to the development of gastroenterology.

[Clinical Practice & Outstanding Contributions] Professor Qian has long held dedicated inflammatory bowel disease clinics, cumulatively treating tens of thousands of patients with IBD and various digestive diseases, with annual outpatient volume ranking among the highest nationwide. Leading her team, she has provided clear diagnoses and developed standardized treatment plans for countless "refractory" inflammatory bowel disease patients, helping many patients avoid surgery or achieve long-term remission. She has been repeatedly recognized as an outstanding physician, and is deeply trusted by patients and respected by peers alike. She is an outstanding expert in the field of inflammatory bowel disease in China.

[Honors & Reputation] Professor Qian Jiaming serves as Director of the Department of Gastroenterology at Peking Union Medical College Hospital and Vice Chair of the Gastroenterology Branch of the Chinese Medical Association, among other academic positions. She has presided over national-level projects including the National Key R&D Program, and is an authoritative expert in the field of inflammatory bowel disease (IBD) in China. She has led the establishment of a Chinese inflammatory bowel disease clinical cohort and national collaboration network, systematically studying the clinical characteristics and treatment strategies of Chinese IBD patients, promoted standardized application of biologics and IBD specialty clinic construction, and participated in the development of Chinese inflammatory bowel disease diagnosis and treatment guidelines, with findings published in authoritative domestic and international journals. For decades on the clinical front lines, she has helped numerous refractory inflammatory bowel disease patients control their conditions and avoid surgery, and is deeply trusted by patients and respected by peers alike.